D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), ...

Large-cap stocks just saw their biggest-ever week of purchases, according to Bank of America data.

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

The new memecoin Flockerz (FLOCK) is gaining traction in its ICO, approaching the $1.5 million funding milestone ...

Partly in light of three new Arm Cortex CPUs launching at Computex in June, Chris Bergey, Arm Senior Vice President and General Manager of its Client Line of Business, sat down with Android Police to ...

Modalis Therapeutics is seeking to make MDL-101 the first treatment for people with LAMA2-related congenital muscular dystrophy.

The technical definition of a bull market is when prices in any asset – such as shares, gold or bonds – rise by 20pc or more from a low point, typically following a period of sliding prices ...

ICON plc (NASDAQ:ICLR) traded sharply lower on Thursday, sparking a selloff among its rival contract research organizations after the Ireland-based company cut its guidance with its Q3 results. In ...

The stock market's overall movements can be described as a repeating cycle that usually has four identifiable stages to it. Understanding the market cycle can help investors make more informed ...

DUBLIN - ICON plc (NASDAQ:ICLR), a healthcare intelligence and clinical research organization, reported third quarter earnings that fell short of analyst expectations, sending shares more than 15% ...

NEW YORK (Reuters) - Banks have been tweaking the terms of commercial real estate mortgages to obscure losses, and in delaying the day of reckoning, are increasing risks to the broader financial ...